Iveda Solutions, Inc. — Form 10-Q Summary
Business Context and Reporting Period
This quarterly report covers the three months ended March 31, 2023. Iveda provides AI-enabled video analytics, IP video surveillance, IoT devices and platforms, smart-power technology, smart-pole solutions, and related services. Operations are conducted primarily in the United States and Taiwan through Iveda Taiwan, which generated approximately $1.98 million, or 90% of reported quarterly revenue.
The filing’s financial statement captions contain inconsistent prior-period labels: certain statements identify the comparison period as March 31, 2021, while management’s discussion and cash-flow disclosures identify it as March 31, 2022. The comparisons below generally follow management’s stated March 31, 2022 comparison.
Financial Highlights
| Metric | Three Months Ended March 31, 2023 | Prior Comparable Period |
|---|---|---|
| Total revenue | $2.205 million | $0.231 million |
| Equipment sales | $2.004 million | $0.190 million |
| Service revenue | $0.201 million | $0.041 million |
| Gross profit | $0.487 million | $0.141 million |
| Gross margin | Approximately 22% | Approximately 61% |
| Operating expenses | $1.038 million | $0.792 million |
| Loss from operations | $(0.551) million | $(0.652) million |
| Net loss | $(0.550) million | $(0.667) million |
| Basic and diluted loss per share | $(0.04) | $(0.07) |
| Net cash provided by operating activities | $0.173 million | $(0.770) million |
Revenue increased approximately 855%, primarily from increased equipment sales by Iveda Taiwan related to delivery timing under long-term contracts awarded and initiated during 2022. Gross profit increased in dollars, but gross margin declined to approximately 22% because the Taiwan project revenue carried lower, more typical margins.
Operating expenses increased approximately 31%, primarily due to additional U.S. administrative, sales, technical-support, investor-relations, and public-relations spending. The estimated operating margin was approximately negative 25%, and the estimated net margin was approximately negative 25%.
Cash Flow, Liquidity, Debt, and Capitalization
- Cash and cash equivalents were $8.380 million at March 31, 2023, compared with $7.312 million at December 31, 2022. Restricted cash was $0.130 million.
- Net cash provided by operating activities was $0.173 million, benefiting primarily from a $0.717 million reduction in accounts receivable, a $0.138 million inventory reduction, and a $0.210 million reduction in other current assets.
- Investing cash outflow was $0.176 million, primarily for property and equipment and development of additional IvedaAI platforms.
- Financing cash inflow was $1.072 million, including $1.323 million of proceeds from the exercise of 945,900 warrants, partially offset by approximately $0.251 million of debt repayments.
- Total debt was approximately $0.404 million at March 31, 2023, consisting of $0.164 million of short-term debt and $0.240 million of long-term debt, including $0.065 million classified as current.
- Accounts receivable declined to $0.506 million from $1.223 million at December 31, 2022. Inventory declined to $0.388 million from $0.526 million.
- Common shares outstanding increased to 16,012,639 at March 31, 2023 from 15,066,739 at December 31, 2022, primarily from warrant exercises. Stockholders’ equity increased to $8.342 million, while accumulated deficit reached $45.257 million.
Material Changes Versus the Prior Comparable Period
- Revenue rose by approximately $1.974 million, or 855%, driven mainly by Taiwan equipment deliveries.
- Cost of revenue increased approximately 1,800% to $1.718 million, causing gross margin to fall from approximately 61% to 22%.
- Operating loss improved by approximately $0.101 million, or 15%, despite higher operating expenses.
- Net loss improved by approximately $0.117 million, or 17%, helped by higher revenue and approximately $19,000 of net other income versus approximately $12,000 of net other expense in the prior period.
- Operating cash flow improved from a use of $0.770 million to positive $0.173 million, while investing outflows increased substantially because of capital expenditures and platform development.
Guidance, Outlook, Risks, and Unusual Items
The filing does not provide formal quantitative revenue or earnings guidance. Management states that the company has incurred significant operating losses since inception and has not established a stabilized revenue base sufficient to cover operating costs at its current burn rate. Management identifies continued revenue growth and/or additional capital-market financing as necessary to support operations and states that there is no assurance either effort will succeed.
- Going-concern and financing risk: Future equity or debt financing may be unavailable or occur on unfavorable terms and could materially dilute existing shareholders or create securities senior to common stock.
- Control weakness: Management concluded that disclosure controls and procedures were not effective as of December 31, 2022. The company plans to add financial personnel and implement additional controls.
- Geographic and customer concentration: Taiwan accounted for approximately 90% of first-quarter revenue. The company has historically depended heavily on Iveda Taiwan and a limited number of customers.
- Credit and deposit exposure: Receivables are unsecured, and cash deposits may exceed FDIC or Taiwan CDIC insurance limits.
- Contingency: Iveda Taiwan had potential exposure of approximately $0.303 million for required after-project services under certain customer contracts.
- Tax attributes: Federal net operating loss carryforwards were approximately $29 million at December 31, 2022, with some beginning to expire in 2025; related deferred tax assets were fully offset by a valuation allowance.
- Equity dilution: The quarter included exercise of 945,900 warrants and an increase in common shares outstanding of approximately 946,000 shares.
- The filing reports no material legal proceedings, no defaults upon senior securities, and no material off-balance-sheet arrangements.
Investor Verification Items
- Verify the correct prior-period comparison, because the filing inconsistently labels certain March 31 comparative statements as 2021 and elsewhere identifies them as 2022.
- Assess whether the large Taiwan equipment deliveries are recurring and whether project margins can improve from the reported 22% gross margin.
- Evaluate the company’s going-concern disclosure, operating burn rate, and ability to fund operations without further dilutive financing.
- Review the remediation status of ineffective disclosure controls and any related financial-reporting risks.
- Review customer and geographic concentration, including dependence on Iveda Taiwan and major Taiwan customers.
- Assess potential dilution from outstanding options and warrants and the effect of future capital raises.
- Monitor the $0.303 million Taiwan after-project-services contingency and the collectability of unsecured receivables.